Your browser doesn't support javascript.
loading
Plasma exosome-derived fragile site-associated tumor suppressor as a powerful prognostic predictor for patients with ovarian cancer.
Hu, Renjing; Chen, Xiaochun; Zhang, Shiliang; Liu, Bin; Pei, Hao; Tu, Fan; Liu, Jun; Yu, Hao.
Afiliação
  • Hu R; Department of Laboratory Medicine, Wuxi Second People's Hospital, Jiangsu, China.
  • Chen X; Department of Laboratory Medicine, Taizhou Second People's Hospital, Taizhou, Jiangsu, China.
  • Zhang S; Department of Laboratory Medicine, Wuxi Fifth People's Hospital, Jiangsu, China.
  • Liu B; Department of Laboratory Medicine, Wuxi Fifth People's Hospital, Jiangsu, China.
  • Pei H; Department of Laboratory Medicine, Wuxi Fifth People's Hospital, Jiangsu, China.
  • Tu F; Department of Laboratory Medicine, Wuxi Fifth People's Hospital, Jiangsu, China.
  • Liu J; Department of Laboratory Medicine, Wuxi Fifth People's Hospital, Jiangsu, China.
  • Yu H; Department of Interventional Oncology, Wuxi Fifth People's Hospital, Jiangsu, China.
Bosn J Basic Med Sci ; 22(3): 453-459, 2022 Jun 01.
Article em En | MEDLINE | ID: mdl-34491890

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Exossomos Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Bosn J Basic Med Sci Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Exossomos Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Bosn J Basic Med Sci Ano de publicação: 2022 Tipo de documento: Article